(Q42049434)

15 October 2017

A-350619: a novel activator of soluble guanylyl cyclase (English)

1 reference

15 October 2017

Loan N Miller

1

1 reference

15 October 2017

Masaki Nakane

2

1 reference

15 October 2017

Gin C Hsieh

3

1 reference

15 October 2017

Renjie Chang

4

1 reference

15 October 2017

Teodozyi Kolasa

5

1 reference

15 October 2017

Robert B Moreland

6

1 reference

15 October 2017

Jorge D Brioni

7

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

15 October 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

15 October 2017

72

1 reference

15 October 2017

9

1 reference

15 October 2017

1015-1025

1 reference

Novel effects of nitric oxide

15 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Antiatherosclerotic activity of drugs in relation to nitric oxide function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Nitric oxide (NO)-related pharmaceuticals: contemporary approaches to therapeutic NO modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Expression of soluble guanylate cyclase activity requires both enzyme subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Localization of the heme binding region in soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Mechanism of YC-1-induced activation of soluble guanylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Interaction of soluble guanylate cyclase with YC-1: kinetic and resonance Raman studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: influence of nitric oxide scavengers and calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Inhibition of soluble guanylate cyclase by ODQ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

NO-independent regulatory site on soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

NO-independent stimulators of soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

Cloning of guanylyl cyclase isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902361-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(02)02361-5

1 reference

15 October 2017

1 reference